On comparing heterogeneity across biomarkers
نویسندگان
چکیده
منابع مشابه
Comparing Suffering Across Species
Moral life often presents us with trade-offs between the sufferings of some individuals and the sufferings of others. Researchers may need to consider, for example, whether the suffering imposed on animals by a certain line of medical experimentation justifies the relief that the resulting discoveries may bring to (human or non-human) others. Often in such cases, the suffering of some individua...
متن کاملMacrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis
Cardiovascular disease (CVD) is a global epidemic, currently representing the worldwide leading cause of morbidity and mortality. Atherosclerosis is the fundamental pathophysiologic component of CVD, where the immune system plays an essential role. Monocytes and macrophages are key mediators in this aspect: due to their heterogeneity and plasticity, these cells may act as either pro- or anti-in...
متن کاملComparing mammographic measures across populations.
Mammography reveals wide variation among women in the composition and structure of the breast, reflecting the cumulative effects of genetic and environmental exposures that may also play roles in breast carcinogenesis (1,2). Mammographic density (MD), one measure of the characteristics of the image, reflects the relative representation of radiodense epithelial and stromal tissues and radiolucen...
متن کاملComparing Prosody Across Many Languages
An empirical metric is developed to measure similarity or distance between the prosodic systems of diverse languages. Two physical variables which carry prosodic information, F0 and amplitude envelope modulation, are used as inputs in a pairwise language discrimination task. A novel neural network model is trained to discriminate among pairs of languages drawn from a set of ten languages in a t...
متن کاملComparing biomarkers as trial level general surrogates.
An intermediate response measure that accurately predicts efficacy in a new setting can reduce trial cost and time to product licensure. In this article, we define a trial level general surrogate, which is an intermediate response that can be used to accurately predict efficacy in a new setting. Methods for evaluating general surrogates have been developed previously. Many methods in the litera...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cytometry Part A
سال: 2014
ISSN: 1552-4922
DOI: 10.1002/cyto.a.22599